Search results

Evidence-based recommendations on enzalutamide (Xtandi) for treating metastatic, hormone-relapsed prostate cancer for people in whom chemotherapy is not yet clinically indicated.

Result type

Technology appraisal guidance

Published

27 January 2016

This quality standard covers how community pharmacies can support the health and wellbeing of the local population. It describes high-quality care in priority areas for improvement.

Result type

Quality standard

Published

28 August 2020

NICE quick guide - moving between hospital and home, including care homes

Result type

Social care quick guide

Published

22 June 2022

This guideline covers assessing, diagnosing and managing mental health problems in adults (aged 18 and over) who are in contact with the criminal justice system. It aims to improve mental health and wellbeing in this population by establishing principles for assessment and management, and promoting more coordinated care planning and service organisation across the criminal justice system.

Result type

NICE guideline

Published

21 March 2017

Evidence-based recommendations on infliximab (Remicade, Inflectra or Remsima), adalimumab (Humira) and golimumab (Simponi) for treating moderate to severe ulcerative colitis in adults, and on infliximab for treating severe active ulcerative colitis in children and young people of 6–17 years.

Result type

Technology appraisal guidance

Published

25 February 2015

Evidence-based recommendations on carfilzomib (Kyprolis) for previously treated multiple myeloma in adults.

Result type

Technology appraisal guidance

Published

18 November 2020

Evidence-based recommendations on larotrectinib (Vitrakvi) for treating neurotrophic tyrosine receptor kinase (NTRK) fusion-positive solid tumours in adults and children.

Result type

Technology appraisal guidance

Published

27 May 2020

This quality standard covers providing and organising services for people with sarcoma. It includes pathways for referral and diagnosis, treatment and support for adults, young people and children with sarcoma. It describes high-quality care in priority areas for improvement.

Result type

Quality standard

Published

29 January 2015

Evidence-based recommendations on filgotinib (Jyseleca) for moderate to severe rheumatoid arthritis in adults.

Result type

Technology appraisal guidance

Published

24 February 2021

Evidence-based recommendations on cenobamate (Ontozry) for treating focal onset seizures with or without secondary generalised seizures in adults with drug-resistant epilepsy that has not been adequately controlled with at least 2 antiseizure medicines.

Result type

Technology appraisal guidance

Published

15 December 2021

Evidence-based recommendations on pembrolizumab (Keytruda) for the adjuvant treatment of resected stage 2B and 2C melanoma in people 12 years and over.

Result type

Technology appraisal guidance

Published

26 October 2022

Evidence-based recommendations on carfilzomib (Kyprolis) with dexamethasone and lenalidomide (Revlimid) for previously treated multiple myeloma in adults.

Result type

Technology appraisal guidance

Published

28 April 2021

Evidence-based recommendations on abiraterone (Zytiga) for newly diagnosed high-risk hormone-sensitive metastatic prostate cancer in adults.

Result type

Technology appraisal guidance

Published

18 August 2021

This quality standard covers the management of colorectal (bowel) cancer in adults. It includes managing local disease and secondary tumours (metastatic disease). It describes high-quality care in priority areas for improvement.

Result type

Quality standard

Last updated

1 February 2022

NICE's leading role in designing a new service to support the development and adoption of AI and data-driven technologies in health and care.